<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Education &amp; Blog on สาขาวิชาโรคไตและการบำบัดทดแทนไต วชิรพยาบาล</title>
    <link>http://www.vajirakidney.org/th/en/blog/</link>
    <description>Recent content in Education &amp; Blog on สาขาวิชาโรคไตและการบำบัดทดแทนไต วชิรพยาบาล</description>
    <generator>Hugo</generator>
    <language>th</language>
    <lastBuildDate>Fri, 28 Feb 2025 00:00:00 +0000</lastBuildDate>
    <atom:link href="http://www.vajirakidney.org/th/en/blog/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Sodamint</title>
      <link>http://www.vajirakidney.org/th/en/blog/sodamint/</link>
      <pubDate>Fri, 28 Feb 2025 00:00:00 +0000</pubDate>
      <guid>http://www.vajirakidney.org/th/en/blog/sodamint/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.facebook.com/share/p/16EHQqj3j5/&#34;&gt;View the original Facebook post&lt;/a&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Sodamint (sodium bicarbonate)&lt;/strong&gt; is probably the tablet nephrologists prescribe the most, yet the evidence that it slows chronic kidney disease remains inconclusive. The rationale is that worsening kidney function reduces the ability to excrete acid, leading to metabolic acidosis. When the blood is persistently acidic the body buffers acid by breaking down protein and bone, and chronic acidosis might accelerate kidney damage. That is the theory—clinical trials are required to confirm whether the drug truly helps.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
